An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease
PHASE2
This study will evaluate the long-term safety and tolerability of UTTR1147A...
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC)
PHASE2
This study is designed to evaluate the efficacy, safety, and pharmacokineti...
Study to Evaluate the Safety and Pharmacokinetics of Efmarodocokin Alfa in Combination With Standard of Care in Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
PHASE1
This is a Phase Ib, open-label, multicenter, dose-escalation study to evalu...
A Safety Study of Intravenously Administered UTTR1147A in Healthy Volunteers (HVs), Participants With Ulcerative Colitis (UC), and Participants With Crohn's Disease (CD)
PHASE1
This is a randomized, observer-blinded, placebo-controlled study to evaluat...